Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Europe Equity ETF (BBEU) Hits New 52-Week High
For investors seeking momentum, JPMorgan BetaBuilders Europe ETF (BBEU - Free Report) is probably on radar. The fund just hit a 52-week high and is up 41.52 % from its 52-week low price of $39.34/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea of where it might be headed:
BBEU in Focus
The underlying Morningstar Developed Europe Target Market Exposure is a free float-adjusted market capitalization-weighted index which consists of equity securities from developed European countries. The product charges 9 bps in annual fees.
Why the Move?
In April, business activity in the Eurozone accelerated. The services industry of the single currency bloc, a dominant sector, experienced an increase in demand that surpassed its already strong performance boosting growth. The travel and leisure sector is also showing positive growth. Plus, there is an indication by the central bankers that they are approaching the limit of their hawkish interest rate policy. This is a plus for overall equity investing.
More Gains Ahead?
Though BBEU has a Zacks ETF Rank #4 (Sell) currently, it might continue its strong performance in the near term, given a positive weighted alpha of 13.22.